Sales decline 0.52% to Rs 51.87 crore
Net Loss of Parenteral Drugs (India) reported to Rs 17.91 crore in the quarter ended March 2013 as against net loss of Rs 35.00 crore during the previous quarter ended March 2012. Sales declined 0.52% to Rs 51.87 crore in the quarter ended March 2013 as against Rs 52.14 crore during the previous quarter ended March 2012.For the Audited full year,net loss reported to Rs 85.20 crore in the year ended March 2013 as against net loss of Rs 47.82 crore during the previous year ended March 2012. Sales declined 15.88% to Rs 187.22 crore in the year ended March 2013 as against Rs 222.56 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales51.8752.14 -1 187.22222.56 -16 OPM %-8.12-29.32 72 -11.833.97 -398 PBDT-11.48-27.30 58 -64.36-30.36 -112 PBT-15.92-31.94 50 -81.70-43.20 -89 NP-17.91-35.00 49 -85.20-47.82 -78
Powered by Capital Market - Live News
